Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Gary Heimberg’s practice focuses on public policy and government affairs matters for pharmaceutical, medical device and consumer health care clients. He has substantive knowledge of the current legislative and policy issues facing the Life Sciences industry, including in the areas of intellectual property, pricing, oversight & investigations, OTC medicines, vaccines, biodefense, and FDA reform. Mr. Heimberg has also facilitated the implementation of internal corporate policies and procedures to adhere to federal compliance requirements.

Mr. Heimberg’s pharmaceutical industry experience spans all spheres, including in-house, trade association, government and private practice positions.

Memberships and Affiliations

  • The George Washington University Law School, Associate Professorial Lecturer (2001-2006)
  • Kids Smiles, Board Member (2010-present)
  • Presidential Management Intern (PMI) Program, Selectee, (1987)

Previous Experience

  • GlaxoSmithKline, Director, Federal Government Relations
  • U.S. Senate Committee on Labor and Human Resources, Professional Staff Member
  • U.S. Senate, Office of the Majority Secretary, Floor Assistant
  • Legal 500 US, Government Relations (2016)